Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.61 |
| ▸ | TFEB | P19484 | 1/20 | 0.61 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | CDK4 | P11802 | 3/20 | 0.56 |
| ▸ | CCND1 | P24385 | 3/20 | 0.56 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.56 |
| ▸ | CDK1 | P06493 | 1/20 | 0.56 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.56 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.56 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | BCHE | P06276 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL228813 | 1.00 | NFE2L2 (0.61) | NFE2L2TFEBTRPA1KDM4ECDK4 | |
| SCHEMBL31004887 | 1.00 | NFE2L2 (0.61) | NFE2L2TFEBTRPA1KDM4ECDK4 | |
| SCHEMBL9900345 | 1.00 | NFE2L2 (0.61) | NFE2L2TFEBTRPA1KDM4ECDK4 | |
| SCHEMBL43264 | 1.00 | NFE2L2 (0.61) | NFE2L2TFEBTRPA1KDM4ECDK4 | |
| SCHEMBL18570324 | 0.86 | CDK4 (0.50) | NFE2L2TFEBTRPA1KDM4ECDK4 | |
| SCHEMBL2119793 | 0.85 | NFE2L2 (0.63) | NFE2L2KDM4ECYP1A1CYP1A2CYP1B1 | |
| SCHEMBL8494360 | 0.85 | NFE2L2 (0.63) | NFE2L2KDM4ECYP1A1CYP1A2CYP1B1 | |
| SCHEMBL4019329 | 0.84 | NFE2L2 (0.79) | NFE2L2TFEBTRPA1KDM4ECYP1A1 | |
| SCHEMBL1603719 | 0.84 | NFE2L2 (0.79) | NFE2L2TFEBTRPA1KDM4ECYP1A1 | |
| SCHEMBL7915752 | 0.84 | NFE2L2 (0.79) | NFE2L2TFEBTRPA1KDM4ECYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117402051-A | Compound containing alpha, beta-unsaturated aldehyde and having conjugated structure and application thereof | 广东远思南药生物科技有限公司 | 2024-01-16 | — | — | CN | claimed |
| US-20220125696-A1 | INFLAMMATION REDUCING COMPOSITION CONTAINING A CANNABIS SATIVA COMPOUND | HAUGHT JOHN CHRISTIAN (US) | 2022-04-28 | — | — | US | claimed |
| WO-2022087052-A1 | INFLAMMATION REDUCING COMPOSITION CONTAINING A CANNABIS SATIVA COMPOUND | HAUGHT JOHN CHRISTIAN (US) | 2022-04-28 | — | — | WO | claimed |
| EP-4544016-A1 | METHODS AND COMPOSITIONS FOR CLEANING COMPRISING A POLYPEPTIDE HAVING THERMOLYSIN ACTIVITY | Danisco US Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2025081158-A1 | EMULSIONS INCLUDING ESSENTIAL OIL COMPONENTS | APEEL TECHNOLOGY, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| CN-113651682-B | Synthesis method of 2-methoxy cinnamaldehyde | 八叶草健康产业研究院(厦门)有限公司 | 2025-01-14 | — | — | CN | disclosed |
| US-20240376409-A1 | FRAGRANCE BEAD COMPOSITION AND USE THEREOF | NOVOZYMES A/S (DK) | 2024-11-14 | — | — | US | disclosed |
| CN-118844491-A | Preservative for sauced duck meat products and preparation method and application thereof | 江西师范大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-118666731-A | 2-Phenylindole derivative and preparation method and application thereof | 东南大学 | 2024-09-20 | — | — | CN | disclosed |
| CN-118576720-A | Application of cinnamon oil as absorption promoter to improvement of puerarin bioavailability | 安徽中医药大学 | 2024-09-03 | — | — | CN | disclosed |
| EP-4229169-B1 | LAUNDRY DETERGENT PORTION UNIT | HENKEL AG & CO KGAA (DE) | 2024-08-07 | — | — | EP | disclosed |
| WO-2022084303-A2 | USE OF POLYPEPTIDES HAVING DNASE ACTIVITY | NOVOZYMES A/S (DK) | 2022-04-28 | — | — | WO | disclosed |
| US-20220125696-A1 | INFLAMMATION REDUCING COMPOSITION CONTAINING A CANNABIS SATIVA COMPOUND | HAUGHT JOHN CHRISTIAN (US) | 2022-04-28 | — | — | US | disclosed |
| WO-2022087052-A1 | INFLAMMATION REDUCING COMPOSITION CONTAINING A CANNABIS SATIVA COMPOUND | HAUGHT JOHN CHRISTIAN (US) | 2022-04-28 | — | — | WO | disclosed |
| EP-3982985-A1 | SAKE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. (US) | 2022-04-20 | — | — | EP | disclosed |
| CN-109851570-B | Chalcone derivative containing 1,2, 4-triazine, preparation method and application thereof | 贵州大学 | 2022-04-19 | — | — | CN | disclosed |
| US-20220105012-A1 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIBACTERIALS | PROCTER & GAMBLE (US) | 2022-04-07 | — | — | US | disclosed |
| CN-114085199-A | Chalcone derivative containing sulfonyl piperazine and preparation method and application thereof | 贵州大学 | 2022-02-25 | — | — | CN | disclosed |
| US-11253451-B2 | Reduction of tooth staining derived from cationic antibacterials | THE PROCTER & GAMBLE COMPANY (US) | 2022-02-22 | — | — | US | disclosed |
| US-20220047484-A1 | Reduction Of Tooth Staining Derived From Cationic Antimicrobials | PROCTER & GAMBLE (US) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220047484-A1 | Reduction Of Tooth Staining Derived From Cationic Antimicrobials | PHOSPHO1, PEF1, DNM1L | NFE2L2 4181/4885TFEB 365/4885TRPA1 1436/4885 |
| US-11253451-B2 | Reduction of tooth staining derived from cationic antibacterials | SOD1, ZRANB2, HDAC10 | NFE2L2 291/4885TFEB 78/4885TRPA1 340/4885 |
| US-20220105012-A1 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIBACTERIALS | SOD1, ZRANB2, HDAC10 | NFE2L2 291/4885TFEB 78/4885TRPA1 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.